Table of Contents 1 Industry Overview 1.1 Leiomyosarcoma Drug Industry 1.1.1 Overview 1.1.2 Development of Leiomyosarcoma Drug 1.2 Market Segment 1.2.1 Upstream 1.2.2 Downstream 1.3 Cost Analysis 2 Industry Environment (PEST Analysis) 2.1 Policy 2.2 Economics 2.3 Sociology 2.4 Technology 3 Leiomyosarcoma Drug Market by Type 3.1 By Type 3.1.1 AL-3818 3.1.2 BGB-290 3.1.3 C-21 3.1.4 Others 3.2 Market Size 3.3 Market Forecast 4 Major Companies List 4.Leiomyosarcoma Drug Advenchen Laboratories, LLC (Company Profile, Sales Data etc.) 4.2 BeiGene, Ltd. (Company Profile, Sales Data etc.) 4.3 Cell Medica Limited (Company Profile, Sales Data etc.) 4.4 Karyopharm Therapeutics, Inc. (Company Profile, Sales Data etc.) 4.5 Merck & Co., Inc. (Company Profile, Sales Data etc.) 4.6 Mirati Therapeutics Inc. (Company Profile, Sales Data etc.) 4.7 Novartis AG (Company Profile, Sales Data etc.) 4.8 Vicore Pharma AB (Company Profile, Sales Data etc.) 5 Market Competition 5.1 Company Competition 5.2 Regional Market by Company 6 Demand by End Market 6.1 Demand Situation 6.1.1 Demand in Clinic 6.1.2 Demand in Hospital 6.1.3 Demand in Others 6.2 Regional Demand Comparison 6.3 Demand Forecast 7 Region Operation 7.1 Regional Production 7.2 Regional Market 7.3 by Region 7.3.1 North America 7.3.1.1 Overview 7.3.1.2 by Country (U.S., Canada, Mexico) 7.3.2 Europe 7.3.2.1 Overview 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.) 7.3.3 Asia-Pacific 7.3.3.1 Overview 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.) 7.3.4 South America 7.3.4.1 Overview 7.3.4.2 by Country (Brazil, Argentina etc.) 7.3.5 Middle East & Africa 7.3.5.1 Overview 7.3.5.2 by Country (Saudi Arabia, South Africa etc.) 7.4 Regional Import & Export 7.5 Regional Forecast 8 Marketing & Price 8.1 Price and Margin 8.1.1 Price Trends 8.1.2 Factors of Price Change 8.1.3 Manufacturers Gross Margin Analysis 8.2 Marketing Channel 9 Research Conclusion

Table Upstream Segment of Leiomyosarcoma Drug Table Application Segment of Leiomyosarcoma Drug Table Global Leiomyosarcoma Drug Market 2013-2024, by Application, in USD Million Table Major Company List of AL-3818 Table Major Company List of BGB-290 Table Major Company List of C-21 Table Major Company List of Others Table Global Leiomyosarcoma Drug Market 2013-2018, by Type, in USD Million Table Global Leiomyosarcoma Drug Market 2013-2018, by Type, in Volume Table Global Leiomyosarcoma Drug Market Forecast 2019-2024, by Type, in USD Million Table Global Leiomyosarcoma Drug Market Forecast 2019-2024, by Type, in Volume Table Advenchen Laboratories, LLC Overview List Table Leiomyosarcoma Drug Business Operation of Advenchen Laboratories, LLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table BeiGene, Ltd. Overview List Table Leiomyosarcoma Drug Business Operation of BeiGene, Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Cell Medica Limited Overview List Table Leiomyosarcoma Drug Business Operation of Cell Medica Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Karyopharm Therapeutics, Inc. Overview List Table Leiomyosarcoma Drug Business Operation of Karyopharm Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Merck & Co., Inc. Overview List Table Leiomyosarcoma Drug Business Operation of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Mirati Therapeutics Inc. Overview List Table Leiomyosarcoma Drug Business Operation of Mirati Therapeutics Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Novartis AG Overview List Table Leiomyosarcoma Drug Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Vicore Pharma AB Overview List Table Leiomyosarcoma Drug Business Operation of Vicore Pharma AB (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Global Leiomyosarcoma Drug Sales Revenue 2013-2018, by Company, in USD Million Table Global Leiomyosarcoma Drug Sales Revenue Share, by Company, in USD Million Table Global Leiomyosarcoma Drug Sales Volume 2013-2018, by Company, in Volume Table Global Leiomyosarcoma Drug Sales Volume Share 2013-2018, by Company, in Volume Table Major Consumers List and Overview Table Regional Demand Comparison List Table Major Application in Different Regions Table Leiomyosarcoma Drug Demand Forecast 2019-2024, by Application, in USD Million Table Leiomyosarcoma Drug Demand Forecast 2019-2024, by Application, in Volume Table Leiomyosarcoma Drug Production 2013-2018, by Region, in USD Million Table Leiomyosarcoma Drug Production 2013-2018, by Region, in Volume Table Global Leiomyosarcoma Drug Market 2013-2018, by Region, in USD Million Table Global Leiomyosarcoma Drug Market Share 2013-2018, by Region, in USD Million Table Global Leiomyosarcoma Drug Market 2013-2018, by Region, in Volume Table Global Leiomyosarcoma Drug Market Share 2013-2018, by Region, in Volume Table North America Leiomyosarcoma Drug Market Size 2013-2018, by Country, in USD Million Table North America Leiomyosarcoma Drug Market Size 2013-2018, by Country, in Volume Table Europe Leiomyosarcoma Drug Market Size 2013-2018, by Country, in USD Million Table Europe Leiomyosarcoma Drug Market Size 2013-2018, by Country, in Volume Table Asia-Pacific Leiomyosarcoma Drug Market Size 2013-2018, by Country, in USD Million Table Asia-Pacific Leiomyosarcoma Drug Market Size 2013-2018, by Country, in Volume Table South America Leiomyosarcoma Drug Market Size 2013-2018, by Country, in USD Million Table South America Leiomyosarcoma Drug Market Size 2013-2018, by Country, in Volume Table Middle East & Africa Leiomyosarcoma Drug Market Size 2013-2018, by Country, in USD Million Table Middle East & Africa Leiomyosarcoma Drug Market Size 2013-2018, by Country, in Volume Table Leiomyosarcoma Drug Market Forecast 2019-2024, by Region, in USD Million Table Leiomyosarcoma Drug Market Forecast 2019-2024, by Region, in Volume Table Price Factors List Figure Global Leiomyosarcoma Drug Market Growth 2013-2018, by Type, in USD Million Figure Global Leiomyosarcoma Drug Market Growth 2013-2018, by Type, in Volume Figure North America Leiomyosarcoma Drug Market Concentration, in 2018 Figure Europe Leiomyosarcoma Drug Market Market Concentration, in 2018 Figure Asia-Pacific Leiomyosarcoma Drug MMarket Concentration, in 2018 Figure South America Leiomyosarcoma Drug Market Concentration, in 2018 Figure Middle East & Africa Leiomyosarcoma Drug Market Concentration, in 2018 Figure Leiomyosarcoma Drug Demand in Clinic, 2013-2018, in USD Million Figure Leiomyosarcoma Drug Demand in Clinic, 2013-2018, in Volume Figure Leiomyosarcoma Drug Demand in Hospital, 2013-2018, in USD Million Figure Leiomyosarcoma Drug Demand in Hospital, 2013-2018, in Volume Figure Leiomyosarcoma Drug Demand in Others, 2013-2018, in USD Million Figure Leiomyosarcoma Drug Demand in Others, 2013-2018, in Volume Figure North America Leiomyosarcoma Drug Market Size and Growth 2013-2018, in USD Million Figure North America Leiomyosarcoma Drug Market Size and Growth 2013-2018, in Volume Figure Europe Leiomyosarcoma Drug Market Size and Growth 2013-2018, in USD Million Figure Europe Leiomyosarcoma Drug Market Size and Growth 2013-2018, in Volume Figure Asia-Pacific Leiomyosarcoma Drug Market Size and Growth 2013-2018, in USD Million Figure Asia-Pacific Leiomyosarcoma Drug Market Size and Growth 2013-2018, in Volume Figure South America Leiomyosarcoma Drug Market Size and Growth 2013-2018, in USD Million Figure South America Leiomyosarcoma Drug Market Size and Growth 2013-2018, in Volume Figure Middle East & Africa Leiomyosarcoma Drug Market Size and Growth 2013-2018, in USD Million Figure Middle East & Africa Leiomyosarcoma Drug Market Size and Growth 2013-2018, in Volume Figure Marketing Channels Overview